Serplulimab represents a significant step in immunotherapy , acting as a novel Immune inhibitor designed to target the interaction between PD-L1 and its receptor . This mechanism enables the patient's immune https://martinayjqr190195.blogdigy.com/serplulimab-a-innovative-protein-blocker-for-cancer-therapy-65674845